SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-15-000460
Filing Date
2015-11-13
Accepted
2015-11-13 10:24:16
Documents
9
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED SEPTEMBER 30, 2015 nnab-20150930_10q.htm 10-Q 184817
2 EXHIBIT 31.1 nnab-20150930_10qex31z1.htm EX-31.1 12137
3 EXHIBIT 32.1 nnab-20150930_10qex32z1.htm EX-32.1 5849
  Complete submission text file 0001520138-15-000460.txt   993618

Data Files

Seq Description Document Type Size
4 XBRL LABEL FILE nnab-20150930_lab.xml EX-101.LAB 94352
5 XBRL PRESENTATION FILE nnab-20150930_pre.xml EX-101.PRE 67993
6 XBRL INSTANCE FILE nnab-20150930.xml EX-101.INS 117661
7 XBRL SCHEMA FILE nnab-20150930.xsd EX-101.SCH 11936
8 XBRL CALCULATION FILE nnab-20150930_cal.xml EX-101.CAL 15145
9 XBRL DEFINITION FILE nnab-20150930_def.xml EX-101.DEF 14131
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 3055154118
NANOANTIBIOTICS, INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 151227406
SIC: 2834 Pharmaceutical Preparations